John J. Xu
6Patents
2h-index
11Co-inventors
44Inventor score
Filing activity: May 4, 2011 → Jan 25, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11058779B2 | Sirna/nanoparticle formulations for treatment of middle-east respiratory syndrome coronaviral infection | Chemistry; Metallurgy | 15 | Active |
| US9642873B2 | Combinations of TGFβ and COX-2 inhibitors and methods for their therapeutic application | Chemistry; Metallurgy | 3 | Active |
| US12006500B2 | Composition and methods of RNAi prophylactics and therapeutics for treatment of severe acute respiratory infection caused by 2019 novel coronavirus (2019-nCoV) | Chemistry; Metallurgy | 1 | Active |
| US9868952B2 | Compositions and methods for “resistance-proof” SiRNA therapeutics for influenza | Chemistry; Metallurgy | 0 | Active |
| US11697813B2 | Pharmaceutical compositions and methods of use for activation of human fibroblast and myofibroblast apoptosis | Chemistry; Metallurgy | 0 | Active |
| US9506063B2 | SiRNA compositions and methods for treatment of HPV and other infections | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.